BORDI, Cesare
 Distribuzione geografica
Continente #
NA - Nord America 2.276
EU - Europa 1.572
AS - Asia 1.124
SA - Sud America 97
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 5.086
Nazione #
US - Stati Uniti d'America 2.221
CN - Cina 591
SG - Singapore 371
IE - Irlanda 338
UA - Ucraina 285
SE - Svezia 274
FI - Finlandia 261
DE - Germania 154
BR - Brasile 84
TR - Turchia 74
NL - Olanda 73
GB - Regno Unito 57
IN - India 56
IT - Italia 55
CA - Canada 51
RU - Federazione Russa 28
BE - Belgio 22
HK - Hong Kong 9
EU - Europa 6
FR - Francia 6
LT - Lituania 6
IR - Iran 5
AR - Argentina 4
EC - Ecuador 4
HU - Ungheria 3
LK - Sri Lanka 3
AL - Albania 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
IQ - Iraq 2
OM - Oman 2
PE - Perù 2
PK - Pakistan 2
PY - Paraguay 2
TW - Taiwan 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
DK - Danimarca 1
DZ - Algeria 1
ES - Italia 1
JM - Giamaica 1
KE - Kenya 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
NP - Nepal 1
RO - Romania 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 5.086
Città #
Chandler 375
Dublin 338
Jacksonville 315
Singapore 227
Santa Clara 225
Beijing 140
Dearborn 138
Ashburn 123
Ann Arbor 116
Boardman 95
Nanjing 83
San Mateo 69
Princeton 68
Izmir 67
Shanghai 58
Pune 48
Wilmington 45
Toronto 43
Woodbridge 35
Helsinki 33
Kunming 33
Nanchang 30
Jinan 25
Los Angeles 25
Shenyang 24
Brussels 22
New York 22
Moscow 21
Parma 21
Hebei 19
Hefei 18
Tianjin 18
Jiaxing 15
Changsha 14
Hangzhou 13
Guangzhou 12
Auburn Hills 11
Bremen 10
Des Moines 9
Haikou 9
Hong Kong 9
Chengdu 7
Dallas 7
Ottawa 7
Council Bluffs 6
Lanzhou 6
Norwalk 6
Wenzhou 6
Zhengzhou 6
Ningbo 5
Seattle 5
São Paulo 5
Turku 5
West Jordan 5
Borås 4
Fremont 4
Fuzhou 4
Houston 4
London 4
Rio Saliceto 4
Sorocaba 4
Taizhou 4
Andover 3
Baotou 3
Belo Horizonte 3
Colombo 3
Falls Church 3
Kocaeli 3
Munich 3
Rockville 3
Abidjan 2
Asunción 2
Baghdad 2
Cairo 2
Clifton 2
Contagem 2
Curitiba 2
Düsseldorf 2
Guayaquil 2
Istanbul 2
Itanhaém 2
Itaquaquecetuba 2
Kashan 2
Leawood 2
Lima 2
Luzzi 2
Marseille 2
Prague 2
Rio de Janeiro 2
Sacramento 2
San Francisco 2
Sopron 2
Taiyuan 2
Tashkent 2
Tirana 2
Viamão 2
Xian 2
Afonso Cláudio 1
Americana 1
Amsterdam 1
Totale 3.210
Nome #
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 123
The assessment of malignancy in endocrine tumours of the gastrointestinal tract 114
Xq25 and Xq26 identify the common minimal deletion region in malignant gastroenteropancreatic endocrine carcinomas 106
p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior 102
Classification of gastric endocrine cells at the light and electron microscopical levels 101
Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract 98
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 98
Endocrine cell replacement of oxyntic glands in Zollinger-Ellison syndrome: a role for female sex hormones? 97
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis 96
Endocrine tumors of the gastrointestinal system 95
The antral mucosa as a new site for endocrine tumors in Multiple Endocrine Neoplasia type-1 and Zollinger Ellison syndromes 93
Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q. 93
The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. 92
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas 91
Pleomorph poorly differentiated endocrine carcinoma of the rectum 90
Malignancy-associated allelic losses on X chromosome in foregut but not in midgut endocrine tumours 90
È L’ANGIOGENESI UN FATTORE PROGNOSTICO NEGLI ADENOCARCINOMI DEL COLON-RETTO IN STADIO B DI DUKES? 90
Loss of heterozygosity at 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome 86
Classification of neuroendocrine tumours 86
Carcinoid tumor associated with vascular malformation as a cause of massive gastric bleeding 86
Poorly differentiated endocrine carcinoma 85
Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. 85
AMPULLARY ADENOCARCINOMA IN VON RECKLINGHAUSEN’S DISEASE. CASE REPORT AND LITERATURE REVIEW. 82
Aetiology, molecular pathogenesis and genetics 82
Biological and molecular aspects of gastroenteropancreatic endocrine tumors. 82
Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture 81
Biclonality of gastric lymphomas 80
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 80
Different patterns of 11q allelic losses in digestive endocrine tumors 80
Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy 78
Endocrine cell growths in atrophic body gastritis. Critical evaluation of a histological classification. 78
Criteria for malignancy in gastrointestinal endocrine tumors 78
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 78
Sporadic colorectal carcinomas with low-level microsatellite instability: a distinct subgroup with specific clinicopathological and molecular features. 76
Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas 75
Presacral carcinoid tumour. Review of the literature and report of a clinically malignant case 73
Multiple endocrine neoplasia type 1 73
Heterotopic mesenteric ossification (Intraabdominal myositis ossificans): Report of five cases 73
Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I 73
Non-functioning tumours and microadenomas 72
Gastric neuroendocrine neoplasms: tumor clonality and malignancy associated large X-chromosomal deletions 72
Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome 69
Highlights on biology of endocrine tumours of the gut and pancreas 69
Pancreatic endocrine tumours: Introduction 67
Mucosal colonization of gastric endocrine tumors mimicking mixed neoplasms 66
Gastrinomas 65
Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas 65
Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases 64
Multiple endocrine neoplasia (MEN)-associated tumours 63
Mixed exocrine-endocrine carcinomas 62
Role of topoisomerase I and thymidylate synthase expression in sporadic colorectal cancer: Associations with clinicopathological and molecular features 61
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin 61
Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection 58
PTU-064 Identification of Syne 1 and Foxe 1 Hypermethylation to improve diagnosis and amangement of colorectal neoplasia in Inflammatory Bowel disease 58
Lack of specific association between gastric autoimmunity hallmarks and clinical presentations of atrophic body gastritis 57
Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma 55
Prognostic factors in gastrointestinal endocrine tumors 55
Sampling strategies for analysis of enterochromaffin-like (ECL) cell changes in Zollinger-Ellison syndrome 55
Occurrence and risk factors for benign epithelial gastric polyps in atrophic body gastritis on diagnosis and follow-up 54
Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas. 54
Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool 53
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization 50
Hypergastrinemia and gastric enterochromaffin-like cells 50
The normal endocrine cell of the gut. Changing concepts and new evidences 48
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 46
Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets 44
Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p 42
Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids 38
Totale 5.092
Categoria #
all - tutte 18.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.844


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202086 0 0 0 0 0 0 0 0 0 0 14 72
2020/2021465 4 65 64 7 63 4 62 4 104 14 69 5
2021/2022367 11 2 2 26 13 7 48 64 17 31 46 100
2022/20231.269 147 135 55 107 114 141 16 73 428 4 37 12
2023/2024414 29 41 5 2 37 153 22 29 5 21 24 46
2024/20251.007 18 78 91 57 170 179 54 56 177 114 13 0
Totale 5.092